A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors

NCT04996121 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Solid Tumors
Locally Advanced or Metastatic Non-small Cell Lung Cancer

Interventions

DRUG: XZP-5955 tablets

Sponsor

Xuanzhu Biopharmaceutical Co., Ltd.